phospho-MEF2C (Ser387) Polyclonal Antibody, PerCP-Cy5.5 Conjugated
Applications
Reactivity
Predicted Reactivity
| Overview | |
| Catalog # | bs-5481R-PerCP-Cy5.5 |
| Product Name | phospho-MEF2C (Ser387) Polyclonal Antibody, PerCP-Cy5.5 Conjugated |
| Applications |
WB
|
| Reactivity | Mouse, Rat |
| Predicted Reactivity | Human, Dog, Rabbit |
| Specifications | |
| Conjugation | PerCP-Cy5.5 |
| Host | Rabbit |
| Source | KLH conjugated synthetic phosphopeptide derived from human MEF2C around the phosphorylation site of Ser387 |
| Modification Site | Ser387 |
| Clonality | Polyclonal |
| Isotype | IgG |
| Concentration | 1ug/ul |
| Purification | Purified by Protein A. |
| Storage Buffer | Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Storage Condition | Store at -20C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target | |
| Gene ID | 4208 |
| Subcellular location | Nucleus |
| Synonyms | MEF2Cphospho S387; MADS box transcription enhancer factor 2 polypeptide C myocyte enhancer factor 2C; Myocyte enhancer factor 2C; Myocyte specic enhancer factor 2C; Similar to MADS box transcription enhancer factor 2 polypeptide C; MEF2C_HUMAN. |
| Background | MEF2C is a transcription activator which binds specifically to the MEF2 element present in the regulatory regions of many muscle-specific genes. This protein controls cardiac morphogenesis and myogenesis, and is also involved in vascular development. It may also be involved in neurogenesis and in the development of cortical architecture. |
| Application Dilution | |
| WB | 1:300-5000 |